VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Aging & HIV 2021COVID Vaccine effectivity in aging population / immune protection (v)View Video
RTRussell TracyPhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Aging & HIV 2021Biological mechanism/ Inflammation, thrombosis & COVID | Russell Tracy, PhD (v)View Video
DBDarren BakerPhD, MSVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Aging & HIV 2021Role of immunosenescent cells in the aging process | Darren Baker, PhD, MS (v)View Video
GBGeorg BehrensMD, PhDVideoHIVManaging HIV Patients With Limited Treatment Options 2021Georg Behrens | Clinical Case #1: New Agents in Patients with Multiple Drug ResistanceView Video
AMGAnna Maria GerettiMD, PhD, FRCPathVideoHIVManaging HIV Patients With Limited Treatment Options 2021Anna Maria Geretti | Epidemiology of Patients with Limited Treatment Options in EuropeView Video
RPRoger ParedesMD, PhDVideoHIVManaging HIV Patients With Limited Treatment Options 2021Roger Paredes | Understanding and Managing Multi-Class ResistanceView Video
CNCClíona Ní CheallaighMB, BAO, BCh, MRCP, PhDVideoHIVManaging HIV Patients With Limited Treatment Options 2021Cliona Ni Cheallaigh | Clinical Case #2: Patient with Immune Non-ResponseView Video
MAMarcus AltfeldMD, PhDVideoHIVManaging HIV Patients With Limited Treatment Options 2021Marcus Altfeld | Immune Non-Responders - A Remaining Unmet NeedView Video
ACAndrea CalcagnoMD, DTM&HVideoHIVManaging HIV Patients With Limited Treatment Options 2021Andrea Calcagno | Pharmacological Considerations in Optimizing Care for Patients with Limited Treatment OptionsView Video
DKDaniel KuritzkesMDVideoHIVManaging HIV Patients With Limited Treatment Options 2021Daniel Kuritzkes | Update on Clinical Trials of Drugs for Patients with Limited Treatment OptionsView Video
JSJonathan SchapiroMDVideoHIVSpanish HIV Clinical Forum 2016Resistance Characteristics of Integrase Inhibitors | Jonathan Schapiro, MDView Video
MBMarta BoffitoMD, PhD, FRCP, MBAVideoHIVSpanish HIV Clinical Forum 2016Pharmacological Considerations in Optimal Integrase Inhibitors Clinical Care | Marta Boffito, MD, PhD, FRCPView Video
